Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTS: NAC for Carpal Tunnel Syndrome
NCT04460521Phase 4Recruiting
- Start
- Apr 2022
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in carpal tunnel syndrome (CTS) comparing NAC + Splinting with Placebo + Splinting (2 arms). Primary endpoint: Boston Carpal Tunnel Questionnaire Score at 8 weeks. Started Apr 2022; status: recruiting.
02
Drugs
acetylcysteine
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on NCT04460521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04460521.